An update from Children with Cancer UK. 7th January 2019
“We welcome the announcement of funding from NHS England for DNA testing for children with cancer to help select the best treatment.
Precision medicine has huge potential for treating cancer in a kinder, more effective way. This is particularly crucial for children, where the toxic treatments can have a serious impact on the long-term health and welfare of those who survive. That’s why since 2017 Children with Cancer UK has invested £3.74 million into pioneering work to put in place the infrastructure that we need for rapid sequencing of tumour DNA and to drive forward the implementation of precision medicine.
We call on NHS England to take this opportunity to significantly scale up access to routine genetic sequencing at all stages of treatment – particularly at relapse – and make precision medicine a reality for all children diagnosed with cancer.”
Grace and Louis’ guide to genetic testing and targeted treatments. Childhood cancer survivor Louis and his twin sister Grace explain Precision Medicine. You are helping us to fund £3.74m for this Precision Medicine research – an exciting new way to deliver cancer treatment to children. Thank you.